These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3321081)

  • 1. Salicylates in Kawasaki disease--a review of clinical pharmacokinetics and efficacy.
    Koren G
    Prog Clin Biol Res; 1987; 250():415-24. PubMed ID: 3321081
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of salicylates in Kawasaki disease.
    Shah D
    Indian Pediatr; 2009 Jul; 46(7):601-2. PubMed ID: 19638660
    [No Abstract]   [Full Text] [Related]  

  • 3. Atypical Kawasaki disease: analysis of clinical presentation and diagnostic clues.
    Levy M; Koren G
    Pediatr Infect Dis J; 1990 Feb; 9(2):122-6. PubMed ID: 2179838
    [No Abstract]   [Full Text] [Related]  

  • 4. Kawasaki disease: management guidelines.
    Nieves-Rivera F; Martin Pumarejo M; Villavicencio R
    Bol Asoc Med P R; 1988 Feb; 80(2):51-3. PubMed ID: 2450550
    [No Abstract]   [Full Text] [Related]  

  • 5. Kawasaki syndrome, Reye syndrome, and aspirin.
    Takahashi M; Mason W
    Pediatrics; 1986 Apr; 77(4):616-7. PubMed ID: 3960631
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacies and risks of aspirin in the treatment of the Kawasaki disease.
    Kusakawa S; Tatara K
    Prog Clin Biol Res; 1987; 250():401-13. PubMed ID: 3423052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mucocutaneous lymph node syndrome, Kawasaki disease. A review and report of 3 cases].
    Rasmussen NH; Pedersen IL; Thelle T; Grymer LF; Christensen MF
    Ugeskr Laeger; 1980 Sep; 142(38):2472-5. PubMed ID: 7445146
    [No Abstract]   [Full Text] [Related]  

  • 8. [The mucocutaneous lymph node syndrome (Kawasaki syndrome). A case with gallbladder hydrops and coronary artery aneurysm].
    Fritz ME; Giambonini S; Jenni R; D'Apuzzo V
    Schweiz Med Wochenschr; 1981 Apr; 111(16):566-71. PubMed ID: 7233135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Kawasaki syndrome: review of the literature and presentation of 4 clinical cases].
    De Martino MP; Grenci G; Costantino D; Mammì F; Stilo L; Costantino G
    Pediatr Med Chir; 1994; 16(1):63-7. PubMed ID: 8029092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salicylates in Kawasaki disease.
    Jacobs JC
    J Pediatr; 1985 May; 106(5):858-9. PubMed ID: 3998932
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mucocutaneous lymph node syndrome or Kawasaki disease].
    Zulaíca D; Ruíz M; Alba A; Higes A; Damiano A
    Rev Clin Esp; 1981 Nov; 163(4):217-20. PubMed ID: 7038786
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin.
    Dale RC; Saleem MA; Daw S; Dillon MJ
    J Pediatr; 2000 Nov; 137(5):723-6. PubMed ID: 11060542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What do we know about Kawasaki disease?
    Kucińska B; Wróblewska-Kałuzewska M
    Med Sci Monit; 2000; 6(6):1227-31. PubMed ID: 11208484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Japanese gamma globulin trials for Kawasaki disease.
    Furusho K; Kamiya T; Nakano H; Kiyosawa N; Shinomiya K; Hayashidera T; Tamura T; Hirose O; Manabe Y; Yokoyama T
    Prog Clin Biol Res; 1987; 250():425-32. PubMed ID: 3321082
    [No Abstract]   [Full Text] [Related]  

  • 15. Kawasaki syndrome in office pediatrics.
    Stein MT
    West J Med; 1984 Oct; 141(4):519-21. PubMed ID: 6506688
    [No Abstract]   [Full Text] [Related]  

  • 16. [Kawasaki disease: a new pediatric nosological entity].
    Campelli A; Mantero E; Marazzi MG; Agnese G; Icardi L; Corazza G; Guarino M; Jannuzzi C
    Pediatr Med Chir; 1983; 5(1-2):119-31. PubMed ID: 6356051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mucocutaneous lymph node syndrome (Kawasaki disease) in adults].
    Horstmann E; Daweke H
    MMW Munch Med Wochenschr; 1982 Oct; 124(42):909-10. PubMed ID: 6819459
    [No Abstract]   [Full Text] [Related]  

  • 18. Determinants of low serum concentrations of salicylates in patients with Kawasaki disease.
    Koren G; Schaffer F; Silverman E; Walker S; Duffy C; Stein L; Suria D; Schue S; Thiessen JJ; Gelfand E
    J Pediatr; 1988 Apr; 112(4):663-7. PubMed ID: 3351695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous gamma globulin therapy in Kawasaki disease--trial of low dose gamma globulin.
    Okuni M; Harada K; Yamaguchi H; Yanagawa H; Sonobe T; Kawasaki T
    Prog Clin Biol Res; 1987; 250():433-9. PubMed ID: 3321083
    [No Abstract]   [Full Text] [Related]  

  • 20. [Kawasaki disease. Description of a case with atypical onset and course].
    Buccino A; Buonagura G; Villani S; Sannino A; Pellegrini F; Cimaglia ML
    Pediatr Med Chir; 1987; 9(4):509-11. PubMed ID: 3697333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.